Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y
Clinical trial NCT00698906 · COMPLETED
Trial details
- NCT number
- NCT00698906
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1997-06-01
- Primary completion
- 1998-02-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.